Inventor · disambiguated record
John Hey
Also filed as: HEY JOHN · HEY JOHN A
16 granted patents·18 pending applications·333 citations·filing 1997–2024
93Inventor score
Top patents by PatentIndex Score
34 records- 0192US6455527B2High affinity ligands for nociceptin receptor ORL-1SCHERING CORP·Filed 2001·Granted Sep 24, 2002·52 cites·9 claims
- 0292US5869479ATreatment of upper airway allergic responsesSCHERING CORP·Filed 1997·Granted Feb 9, 1999·133 cites·8 claims
- 0391US6262066B1High affinity ligands for nociceptin receptor ORL-1SCHERING CORP·Filed 1999·Granted Jul 17, 2001·85 cites·16 claims
- 0490US11053192B2Compositions and methods for treating and preventing neurodegenerative disordersALZHEON INC·Filed 2020·Granted Jul 6, 2021·2 cites·5 claims
- 0588US12187668B2Compositions and methods for treating and preventing neurodegenerative disordersALZHEON INC·Filed 2022·Granted Jan 7, 2025·1 cites·7 claims
- 0685US10590070B2Compositions and methods for treating and preventing neurodegenerative disordersALZHEON INC·Filed 2016·Granted Mar 17, 2020·3 cites·9 claims
- 0785US10471029B2Methods for treating neurological disordersALZHEON INC·Filed 2015·Granted Nov 12, 2019·7 cites·14 claims
- 0884US8524697B2C20-C21 substituted glucocorticoid receptor agonistsANTHES JOHN C·Filed 2008·Granted Sep 3, 2013·20 cites·7 claims
- 0982US11077095B2Methods for treating neurodegenerative disordersALZHEON INC·Filed 2018·Granted Aug 3, 2021·1 cites·4 claims
- 1079US6716846B2High affinity ligands for nociceptin receptor ORL-1SCHERING CORP·Filed 2002·Granted Apr 6, 2004·11 cites·9 claims
- 1179US2024325354A1Methods for treating neurodegenerative disordersALZHEON INC·Filed 2024·Application pending·0 cites
- 1278US12083082B2Methods for treating neurodegenerative disordersALZHEON INC·Filed 2019·Granted Sep 10, 2024·1 cites·9 claims
- 1378US11191742B2Methods of treating neurodegenerative disorders in a particular populationALZHEON INC·Filed 2016·Granted Dec 7, 2021·2 cites·19 claims
- 1478US6906081B2Use of dual H3/M2 antagonists in the treatment of cognition deficit disordersSCHERING CORP·Filed 2002·Granted Jun 14, 2005·11 cites·4 claims
- 1573US12036208B2Methods for treating neurodegenerative disordersALZHEON INC·Filed 2021·Granted Jul 16, 2024·0 cites·2 claims
- 1671US7094784B2High affinity ligands for nociceptin receptor ORL-1SCHERING CORP·Filed 2004·Granted Aug 22, 2006·4 cites·6 claims
- 1771US2025213507A1Methods for treating neurodegenerative disordersALZHEON INC·Filed 2024·Application pending·0 cites
- 1870US2023087041A1Methods for treating neurological disordersALZHEON INC·Filed 2022·Application pending·0 cites
- 1970US2023414541A1Methods of treating neurodegenerative disorders in a particular populationALZHEON INC·Filed 2023·Application pending·0 cites
- 2066US2020101031A1Methods for treating neurological disordersALZHEON INC·Filed 2019·Application pending·0 cites
- 2165US12285400B2Sulfopropanoic acid derivatives for treating neurodegenerative disordersALZHEON INC·Filed 2019·Granted Apr 29, 2025·0 cites·16 claims
- 2263US2025345298A1Apoe4 correctors and methods of useALZHEON INC·Filed 2023·Application pending·0 cites
- 2362US2022096406A1Methods of treating neurodegenerative disorders in a particular populationALZHEON INC·Filed 2021·Application pending·0 cites
- 2455US2025127734A1Alz-801 for use in treating a covid-19 associated neurological symptomALZHEON INC·Filed 2023·Application pending·0 cites
- 2551US2025041248A1Alz-801 for use in treating alzheimer's diseaseALZHEON INC·Filed 2022·Application pending·0 cites
- 2651US2005090527A1Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitisSCHERING CORP·Filed 2004·Application pending·0 cites
- 2751US2004067950A1High affinity ligands for nociceptin receptor ORL-1SCHERING PLOUGH CORP·Filed 2003·Application pending·0 cites
- 2847US2014155334A1Polyphosphate and pyrophosphate derivative of saccharidesLEHN JEAN-MARIE·Filed 2013·Application pending·0 cites
- 2947US2011262368A1C21 thioethers as glucocorticoid receptor agonistsSCHERING CORP·Filed 2008·Application pending·0 cites
- 3046US2014142052A1Phosphorylated polyols, pyrophosphates, and derivatives thereof having biological activityNORMOXYS INC·Filed 2013·Application pending·0 cites
- 3146US2018250249A1Methods of treating neurodegenerative disorders in a particular populationALZHEON INC·Filed 2014·Application pending·0 cites
- 3244US2004198743A1Methods for treating allergic skin and allergic ocular conditions using combinations of histamine receptor antagonistsSCHERING CORP·Filed 2004·Application pending·0 cites
- 3344US2014088036A1Polyphosphate and pyrophosphate derivative of saccharidesLEHN JEAN MARIE·Filed 2011·Application pending·0 cites
- 3441US2023024950A1Methods for treating neurodegenerative disordersALZHEON INC·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →